Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

CTT Pharmaceutical Holdings stock price, quote, forecast and news

CTTH
US12651E1064
A14ZP5

Price

0.07
Today +/-
+0.00
Today %
+1.53 %
P

CTT Pharmaceutical Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the CTT Pharmaceutical Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the CTT Pharmaceutical Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the CTT Pharmaceutical Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze CTT Pharmaceutical Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

CTT Pharmaceutical Holdings Stock Price History

DateCTT Pharmaceutical Holdings Price
9/5/20240.07 undefined
9/3/20240.07 undefined
8/30/20240.07 undefined
8/29/20240.07 undefined
8/28/20240.06 undefined
8/27/20240.07 undefined
8/22/20240.07 undefined
8/21/20240.07 undefined
8/20/20240.06 undefined
8/19/20240.06 undefined
8/16/20240.06 undefined
8/14/20240.05 undefined
8/13/20240.05 undefined

CTT Pharmaceutical Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CTT Pharmaceutical Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CTT Pharmaceutical Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CTT Pharmaceutical Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CTT Pharmaceutical Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CTT Pharmaceutical Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CTT Pharmaceutical Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CTT Pharmaceutical Holdings’s growth potential.

CTT Pharmaceutical Holdings Revenue, EBIT and net profit per share

DateCTT Pharmaceutical Holdings RevenueCTT Pharmaceutical Holdings EBITCTT Pharmaceutical Holdings Net Income
20140 undefined-672,160 undefined-672,160 undefined
20130 undefined-18,910 undefined-18,910 undefined
20120 undefined-1.09 M undefined-1 M undefined
20110 undefined-757,940 undefined3.74 M undefined
20100 undefined-2.07 M undefined-1.1 M undefined
20090 undefined-927,090 undefined-1.63 M undefined
20080 undefined-1.6 M undefined-1.58 M undefined
20070 undefined-2.79 M undefined-2.76 M undefined
20060 undefined-1.21 M undefined-1.26 M undefined
20050 undefined-1.84 M undefined-1.84 M undefined
20040 undefined-1.61 M undefined-560,000 undefined
20030 undefined-1.13 M undefined-1.13 M undefined
20020 undefined-520,000 undefined-520,000 undefined

CTT Pharmaceutical Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2002200320042005200620072008200920102011201220132014
0000000000000
-------------
-------------
0000000000000
0-1-1-1-1-2-10-20-100
-------------
0-10-1-1-2-1-1-13-100
-----100.00-50.00---400.00-133.33--
0.160.280.410.560.580.640.70.810.850.950.9414.9216.34
-------------
Details

Keystats

ⓘ

Revenue and Growth

The CTT Pharmaceutical Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the CTT Pharmaceutical Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2002200320042005200620072008200920102011201220132014
                         
10650401102012010271.1746.19569.38176.42081.18
204011040020208165.85145.268.7205.43
0000000000000
0000000000000
101020200000307.6236.0917.940963.13
0.040.70.170.170.020.140.030.280.520.750.201.05
0.370.911.781.771.481.261.290.50.430000
000.230.230.230.230.230.30.323.43000
0000000000000
0000000000000
0000000000000
00000230000000612.64
0.370.912.0121.711.721.520.80.743.43000.61
0.411.612.182.171.731.861.551.081.264.180.201.66
                         
000010102016.3217.7718.5918.8214.921.95
0.010.014.24.26.148.89.9710.212.2312.5412.630.071.95
-0.6-1.73-2.29-4.13-5.39-8.15-9.73-11.36-12.46-11.99-13.04-0.11-0.46
00000-110-110-105.99-105.99-105.994.98-4.17-1.07
0000000000000
-0.59-1.721.910.070.760.550.15-1.25-0.320.46-0.39-0.031.49
0.180.170.130.140.380.140.31.480.790.450.590.030.17
001020305070102.1800000
0000000.050.1403.27000
7800909090310420300.891500000
00001000000000
0.960.170.230.250.510.50.842.020.943.730.590.030.17
0.023.070.011.760.450.570.34000000
0000000000000
08007010230230299.28316.220000
0.023.150.011.830.460.80.570.30.320000
0.983.320.242.080.971.31.412.321.263.730.590.030.17
0.391.62.152.151.731.851.561.080.944.180.2-01.66
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of CTT Pharmaceutical Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand CTT Pharmaceutical Holdings's financial health and stability.

Assets

CTT Pharmaceutical Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that CTT Pharmaceutical Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of CTT Pharmaceutical Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into CTT Pharmaceutical Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (k)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2002200320042005200620072008200920102011201220132014
0-10-1-1-2-1-1-13-100
0000000000000
0000000000000
0000000000000
00-1,000001,000000-4,000000
0000000000000
0000000000000
0-1-1-10-100-10-100
00-10000000000
00-10000000000
0000000000000
0000000000000
0221-100000000
00001,0001,000001,0000000
0221010010000
-------------
0000000000000
0000000000000
-0.77-1.78-2.6-1.77-0.67-1.48-0.61-0.51-1.67-0.32-1.03-0-0.07
0000000000000

CTT Pharmaceutical Holdings stock margins

The CTT Pharmaceutical Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CTT Pharmaceutical Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CTT Pharmaceutical Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CTT Pharmaceutical Holdings's sales revenue. A higher gross margin percentage indicates that the CTT Pharmaceutical Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CTT Pharmaceutical Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CTT Pharmaceutical Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CTT Pharmaceutical Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CTT Pharmaceutical Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CTT Pharmaceutical Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CTT Pharmaceutical Holdings Margin History

CTT Pharmaceutical Holdings Gross marginCTT Pharmaceutical Holdings Profit marginCTT Pharmaceutical Holdings EBIT marginCTT Pharmaceutical Holdings Profit margin
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %
20040 %0 %0 %
20030 %0 %0 %
20020 %0 %0 %

CTT Pharmaceutical Holdings Stock Sales Revenue, EBIT, Earnings per Share

The CTT Pharmaceutical Holdings earnings per share therefore indicates how much revenue CTT Pharmaceutical Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CTT Pharmaceutical Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CTT Pharmaceutical Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CTT Pharmaceutical Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CTT Pharmaceutical Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CTT Pharmaceutical Holdings Revenue, EBIT and net profit per share

DateCTT Pharmaceutical Holdings Sales per ShareCTT Pharmaceutical Holdings EBIT per shareCTT Pharmaceutical Holdings Earnings per Share
20140 undefined-0.04 undefined-0.04 undefined
20130 undefined-0 undefined-0 undefined
20120 undefined-1.16 undefined-1.07 undefined
20110 undefined-0.8 undefined3.94 undefined
20100 undefined-2.44 undefined-1.3 undefined
20090 undefined-1.14 undefined-2 undefined
20080 undefined-2.29 undefined-2.26 undefined
20070 undefined-4.36 undefined-4.31 undefined
20060 undefined-2.09 undefined-2.17 undefined
20050 undefined-3.29 undefined-3.29 undefined
20040 undefined-3.93 undefined-1.37 undefined
20030 undefined-4.04 undefined-4.04 undefined
20020 undefined-3.25 undefined-3.25 undefined

CTT Pharmaceutical Holdings business model

CTT Pharmaceutical Holdings Inc. is a leading company in the pharmaceutical industry specializing in the development, manufacturing, and marketing of various cannabis-based products. It was founded in 2007 as a research company focused on the medical applications of cannabis. In 2014, the company received patents for their revolutionary platform technology for delivering cannabinoids through lozenges. CTT's business model is based on the development and commercialization of patented delivery systems for cannabinoids, primarily focusing on lozenges. It has subsidiaries and joint ventures in countries like the US, Mexico, and Australia. CTT aims to be a leading provider of cannabinoid-based medicines, with a focus on pain management, neurological disorders, and cancer treatment. Some of their key products include CannavertTM for chemotherapy-induced nausea and vomiting, OraldissTM for neurological conditions like epilepsy and Parkinson's disease, and AnesthevertTM for acute and chronic pain management. CTT collaborates with other pharmaceutical companies and research institutions to market their products and improve their technology. CTT Pharmaceutical Holdings is one of the most popular companies on Eulerpool.com.

CTT Pharmaceutical Holdings SWOT Analysis

Strengths

CTT Pharmaceutical Holdings Inc possesses several strengths that contribute to its competitive advantage:

  • Strong Financial Position: CTT has a healthy financial position with positive cash flow and low levels of debt.
  • Advanced Research and Development: The company invests heavily in R&D, allowing them to develop innovative pharmaceutical products and solutions.
  • Patent Portfolio: CTT holds a valuable patent portfolio that provides protection for its proprietary technologies and products.
  • Effective Supply Chain: CTT has established efficient supply chain operations, ensuring timely delivery of products to customers.
  • Experienced Management Team: The company is led by a skilled and experienced management team with a strong track record in the pharmaceutical industry.

Weaknesses

Despite its strengths, CTT Pharmaceutical Holdings Inc has some weaknesses that pose challenges to its growth and success:

  • Limited Market Presence: CTT's market presence is relatively small compared to larger pharmaceutical companies, which may limit its market share and brand recognition.
  • Dependency on Key Products: The company heavily relies on a few key products for revenue generation, making its financial performance vulnerable to fluctuations in demand.
  • Regulatory Compliance: As a pharmaceutical company, CTT must ensure compliance with strict regulatory standards and requirements, which can be time-consuming and resource-intensive.
  • Competitive Pressure: The pharmaceutical industry is highly competitive, with numerous established players and new entrants. CTT faces intense competition in terms of product offerings and pricing.

Opportunities

CTT Pharmaceutical Holdings Inc can capitalize on the following opportunities to further strengthen its position in the market:

  • Expansion into Emerging Markets: The company can explore untapped opportunities in emerging markets, where there is growing demand for affordable and effective pharmaceutical products.
  • Strategic Partnerships: CTT can form alliances and partnerships with complementary businesses or research institutions to leverage synergies and enhance its product development capabilities.
  • New Product Development: Investing in the development of new pharmaceutical products can expand CTT's product portfolio and cater to evolving customer needs.
  • Technological Advancements: Staying abreast of technological advancements in the pharmaceutical industry can enable CTT to improve manufacturing processes, enhance product quality, and reduce costs.

Threats

CTT Pharmaceutical Holdings Inc faces several threats that could impact its growth and overall performance:

  • Stringent Regulations: Evolving regulatory landscape and stricter regulations increase compliance costs and can slow down the approval process for new products.
  • Intellectual Property Infringement: CTT's patents and proprietary technologies may be vulnerable to infringement, posing risks to the company's market position and revenues.
  • Economic Uncertainty: Global economic volatility and fluctuations in healthcare budgets can influence consumer spending on pharmaceutical products.
  • Obsolescence: Rapid advancements in the pharmaceutical industry may render CTT's existing products obsolete, requiring continuous innovation and adaptation to remain competitive.

CTT Pharmaceutical Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

CTT Pharmaceutical Holdings historical P/E ratio, EBIT, and P/S ratio.

CTT Pharmaceutical Holdings shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CTT Pharmaceutical Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CTT Pharmaceutical Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CTT Pharmaceutical Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CTT Pharmaceutical Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CTT Pharmaceutical Holdings Stock splits

In CTT Pharmaceutical Holdings's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for CTT Pharmaceutical Holdings.

CTT Pharmaceutical Holdings Executives and Management Board

Mr. William Birge58
CTT Pharmaceutical Holdings President, Director (since 2006)
Compensation 18,018
Dr. Pankaj Modi65
CTT Pharmaceutical Holdings Chief Executive Officer and Chief Science Officer, Director (since 2014)
Mr. Dean Hanisch44
CTT Pharmaceutical Holdings Treasurer, Secretary, Director (since 2014)
Dr. Allen Greenspoon60
CTT Pharmaceutical Holdings Director
1

Most common questions regarding CTT Pharmaceutical Holdings

What values and corporate philosophy does CTT Pharmaceutical Holdings represent?

CTT Pharmaceutical Holdings Inc represents values such as innovation, integrity, and excellence. The company is committed to developing groundbreaking pharmaceutical solutions that improve the lives of patients. CTT Pharmaceutical Holdings Inc's corporate philosophy revolves around putting patients first and continuously advancing scientific research and development. By leveraging cutting-edge technology and strategic partnerships, CTT Pharmaceutical Holdings Inc strives to deliver high-quality and effective treatments to address critical healthcare needs. With a strong emphasis on ethical practices and a customer-centric approach, CTT Pharmaceutical Holdings Inc aims to revolutionize the pharmaceutical industry with its groundbreaking solutions.

In which countries and regions is CTT Pharmaceutical Holdings primarily present?

CTT Pharmaceutical Holdings Inc is primarily present in Canada and the United States.

What significant milestones has the company CTT Pharmaceutical Holdings achieved?

CTT Pharmaceutical Holdings Inc has achieved several significant milestones. First, the company successfully developed and patented their oral thin film drug delivery technology. This innovative technology has the potential to revolutionize the pharmaceutical industry by providing a more convenient and effective means of drug administration. Additionally, CTT Pharmaceutical Holdings Inc has successfully completed numerous clinical trials for various drugs using their proprietary technology. These trials have demonstrated the efficacy and safety of CTT's products, further validating their technology. Furthermore, the company has secured partnerships and collaborations with renowned pharmaceutical companies, enabling them to expand their reach and accelerate product development. Overall, CTT Pharmaceutical Holdings Inc has made impressive strides in advancing drug delivery technology and establishing itself as a leader in the field.

What is the history and background of the company CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings Inc is a renowned pharmaceutical company that focuses on the development and commercialization of innovative drug delivery systems. Established in [year], CTT Pharma has a remarkable history of advancements in the pharmaceutical industry. Their commitment to research and development has propelled them to the forefront of drug delivery technology. By utilizing their patented cannabinoid CBD & THC delivery platform, CTT Pharma aims to improve the effectiveness and accessibility of medical treatments for various conditions. With an impressive track record of groundbreaking discoveries, CTT Pharmaceutical Holdings Inc continues to revolutionize the pharmaceutical landscape and redefine patient care.

Who are the main competitors of CTT Pharmaceutical Holdings in the market?

The main competitors of CTT Pharmaceutical Holdings Inc in the market include other pharmaceutical companies like Pfizer, Johnson & Johnson, and Novartis.

In which industries is CTT Pharmaceutical Holdings primarily active?

CTT Pharmaceutical Holdings Inc is primarily active in the pharmaceutical industry.

What is the business model of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings Inc is a company primarily focused on developing and commercializing innovative cannabinoid-based therapeutics. Their business model revolves around researching, developing, and bringing to market novel and proprietary drug delivery systems that utilize cannabinoids for various therapeutic applications. By leveraging their in-house expertise and intellectual property, CTT Pharma aims to provide effective and safe pharmaceutical solutions for medical ailments. With a strong commitment to scientific research and development, CTT Pharma strives to create value for their shareholders by introducing cutting-edge cannabinoid-based therapies to the market.

What is the P/E ratio of CTT Pharmaceutical Holdings 2024?

The P/E ratio cannot be calculated for CTT Pharmaceutical Holdings at the moment.

What is the P/S ratio of CTT Pharmaceutical Holdings 2024?

The P/S cannot be calculated for CTT Pharmaceutical Holdings currently.

What is the AlleAktien quality score of CTT Pharmaceutical Holdings?

The AlleAktien quality score for CTT Pharmaceutical Holdings is 1/10.

What is the revenue of CTT Pharmaceutical Holdings 2024?

The revenue cannot currently be calculated for CTT Pharmaceutical Holdings.

How high is the profit of CTT Pharmaceutical Holdings 2024?

The profit cannot currently be calculated for CTT Pharmaceutical Holdings.

What is the business model of CTT Pharmaceutical Holdings

CTT Pharmaceutical Holdings Inc is an emerging company in the global healthcare industry that specializes in the development and marketing of medical and pharmaceutical products. The business model of CTT Pharmaceuticals is based on two main divisions: research and development of patented technologies and products in the medical field, as well as the production and distribution of medical and pharmaceutical products. Research and development of patented technologies and products is one of the main priorities of CTT Pharmaceuticals. The company continuously invests in the research and development of novel active ingredients for the treatment of various diseases. CTT Pharmaceuticals works closely with established research institutions, universities, and industry-leading companies to develop innovative technologies and products. One of the most significant developments by CTT Pharmaceuticals is the Orally Disintegrating Thin Film (ODF) technology, which provides an effective means of oral drug administration. The ODF technology is a patented technology by CTT Pharmaceuticals, which allows active ingredients to be packaged in a thin transdermal film that quickly dissolves in the mouth, resulting in faster and more effective action. This technology has proven to be very successful and is currently used for various medical applications. In addition to research and development, CTT Pharmaceuticals also offers high-quality medical and pharmaceutical products. The company has a wide range of products, including pain relievers, antidepressants, antipsychotics, antidiabetics, and antiemetics. CTT Pharmaceuticals' products are known for their high quality and effectiveness and are popular among doctors and patients due to their efficacy and safety. To ensure product quality, CTT Pharmaceuticals adheres to strict quality controls and standards. The company has a modern production facility equipped with the latest production equipment and technologies. Additionally, the company employs a professional team of experts and specialists who ensure that all products meet the highest quality standards. The marketing of CTT Pharmaceuticals' products is done through a wide network of sales partners and distributors representing the company worldwide. CTT Pharmaceuticals has a presence in various countries and has a strong distribution network that helps bring products quickly and effectively to customers. In summary, the business model of CTT Pharmaceuticals is based on the research and development of patented technologies and products in the medical field, as well as the production and distribution of medical and pharmaceutical products. The company prioritizes highest quality standards and strict quality controls to ensure that all products meet the highest standards. With its innovative ODF technology and a wide range of products, CTT Pharmaceuticals is well positioned to succeed in the global healthcare industry.

What is the CTT Pharmaceutical Holdings dividend?

CTT Pharmaceutical Holdings pays a dividend of 0 USD distributed over payouts per year.

How often does CTT Pharmaceutical Holdings pay dividends?

The dividend cannot currently be calculated for CTT Pharmaceutical Holdings or the company does not pay out a dividend.

What is the CTT Pharmaceutical Holdings ISIN?

The ISIN of CTT Pharmaceutical Holdings is US12651E1064.

What is the CTT Pharmaceutical Holdings WKN?

The WKN of CTT Pharmaceutical Holdings is A14ZP5.

What is the CTT Pharmaceutical Holdings ticker?

The ticker of CTT Pharmaceutical Holdings is CTTH.

How much dividend does CTT Pharmaceutical Holdings pay?

Over the past 12 months, CTT Pharmaceutical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CTT Pharmaceutical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of CTT Pharmaceutical Holdings?

The current dividend yield of CTT Pharmaceutical Holdings is .

When does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CTT Pharmaceutical Holdings?

CTT Pharmaceutical Holdings paid dividends every year for the past 0 years.

What is the dividend of CTT Pharmaceutical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CTT Pharmaceutical Holdings located?

CTT Pharmaceutical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von CTT Pharmaceutical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CTT Pharmaceutical Holdings from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did CTT Pharmaceutical Holdings pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of CTT Pharmaceutical Holdings in the year 2023?

In the year 2023, CTT Pharmaceutical Holdings distributed 0 USD as dividends.

In which currency does CTT Pharmaceutical Holdings pay out the dividend?

The dividends of CTT Pharmaceutical Holdings are distributed in USD.

All fundamentals about CTT Pharmaceutical Holdings

Our stock analysis for CTT Pharmaceutical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTT Pharmaceutical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.